Literature DB >> 28985614

Complement system dysregulation in patients affected by Idiopathic Generalized Epilepsy and the effect of antiepileptic treatment.

Claudio Liguori1, Andrea Romigi2, Francesca Izzi3, Fabio Placidi3, Marzia Nuccetelli4, Alberto Cordella5, Sergio Bernardini4, Mercuri Nicola Biagio6.   

Abstract

Complement system dysregulation has been hypothesized as a possible pathogenetic factor triggering epileptogenesis in both animal models and human studies. The aim of the present study is to evaluate the complement system in adult patients affected by idiopathic generalized epilepsy (IGE), either untreated or treated by antiepileptic drugs (AEDs). Thirty-seven IGE patients were compared to a population of 20 matched healthy controls. IGE patients underwent neurological investigation, epilepsy diary, 24-h EEG recording, and blood sample for the assessment of the complement factors C3 and C4, fibrinogen, and C-reactive protein (CRP) serum levels. We excluded patients with clinical and subclinical seizures in the 24h before obtaining the blood sample. We observed decreased C3 and C4 serum levels in IGE patients with respect to controls (p<0.05), and in untreated compared to treated IGE patients (p<0.05). We found significant correlations in the IGE group linking C3 to C4 (R=0.34), CRP (R=0.49), and fibrinogen serum levels (R=0.61). This study proved a significant alteration of the complement system in IGE patients not related to ictal conditions. The hyperactivation of the complement cascade was more significant in untreated than in treated IGE patients. Hence, this study documented the complement factors dysregulation in patients affected by IGE. However, the impact of complement system alteration in the epileptogenetic process needs to be clarified.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-epileptic drugs; C3; C4; Complement system; Idiopathic Generalized Epilepsy

Mesh:

Substances:

Year:  2017        PMID: 28985614     DOI: 10.1016/j.eplepsyres.2017.09.005

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  8 in total

Review 1.  Inflammation in CNS neurodegenerative diseases.

Authors:  Jodie Stephenson; Erik Nutma; Paul van der Valk; Sandra Amor
Journal:  Immunology       Date:  2018-04-17       Impact factor: 7.397

Review 2.  Neuroinflammation and Proinflammatory Cytokines in Epileptogenesis.

Authors:  Alireza Soltani Khaboushan; Niloufar Yazdanpanah; Nima Rezaei
Journal:  Mol Neurobiol       Date:  2022-01-11       Impact factor: 5.590

Review 3.  Aberrant Complement System Activation in Neurological Disorders.

Authors:  Karolina Ziabska; Malgorzata Ziemka-Nalecz; Paulina Pawelec; Joanna Sypecka; Teresa Zalewska
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

4.  Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine.

Authors:  Claudio Liguori; Francesca Izzi; Natalia Manfredi; Nicola Biagio Mercuri; Fabio Placidi
Journal:  Epilepsy Behav Case Rep       Date:  2018-03-12

5.  Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add-on therapy compared to levetiracetam and valproic acid.

Authors:  Claudio Liguori; Katherine Turner; Francesca Izzi; Martina Assogna; Maria P Canevini; Nicola B Mercuri; Fabio Placidi
Journal:  CNS Neurosci Ther       Date:  2019-01-23       Impact factor: 5.243

6.  Elevated Blood C-Reactive Protein Levels in Patients With Epilepsy: A Systematic Review and Meta-Analysis.

Authors:  Rui Zhong; Qingling Chen; Mengmeng Li; Xinyue Zhang; Weihong Lin
Journal:  Front Neurol       Date:  2019-09-18       Impact factor: 4.003

7.  Complement C3 Aggravates Post-epileptic Neuronal Injury Via Activation of TRPV1.

Authors:  Guang-Tong Jiang; Lin Shao; Shuo Kong; Meng-Liu Zeng; Jing-Jing Cheng; Tao-Xiang Chen; Song Han; Jun Yin; Wan-Hong Liu; Xiao-Hua He; Yu-Min Liu; Lanzi Gongga; Bi-Wen Peng
Journal:  Neurosci Bull       Date:  2021-07-26       Impact factor: 5.271

8.  TMT-Based Proteomic Analysis of Plasma from Children with Rolandic Epilepsy.

Authors:  Ji Sun; Tiechao Jiang; Feng Gu; Dihui Ma; Jianmin Liang
Journal:  Dis Markers       Date:  2020-10-07       Impact factor: 3.434

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.